Tecentriq HCP Website May 7, 2018 Brand: Tecentriq (atezolizumab), Intravenous Infusion Parent Company: Genentech Drug Type: Prescription Drug Category: Oncology Campaign: Post-Launch Targeting: HCPs Patient Website: https://www.tecentriq.com/patient.html HCP Website: https://www.tecentriq.com/hcp.html Homepage Indication 1 Clinical Data MOA Homepage (Mobile) Mobile Navigation